Maresin-1 and maresin-2 as synovial fluid biomarkers in psoriatic, rheumatoid, and osteoarthritis

• by Sukru Demir, Bugra Can, Omer Esmez, Mustafa Ata Aydin, Sevval Yagmur Gencer, Furkan Bildirici, Süleyman Serdar Koca, İbrahim Sahin, Suleyman Aydin

• July 14, 2026

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

• by Kathryn Wighton

• May 29, 2026

• 5 min

Hair Repigmentation Reported With Baricitinib in Canities Subita

A single case suggests a possible benefit, but confounding factors and the off-label setting temper the conclusions.

• by Andrea Surnit

• June 15, 2026

• 4 min

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.

• by Kathryn Wighton

• June 29, 2026

• 3 min